Assessment of Analytical Quality in Clinical Laboratory Using Sigma Metrics
DOI:
https://doi.org/10.47419/bjbabs.v7i3.477Keywords:
Analytical Quality, Total Allowable Error, Bias, Coefficient of Variation, Quality Control, six sigma metricsAbstract
Background: Analytical quality in clinical laboratories is crucial for generating reliable test results that directly influence diagnosis and patient management. Traditional indicators, such as precision and accuracy, provide only partial assessment. Six sigma metrics offer a comprehensive, quantitative approach by integrating total allowable error (TEa), bias, and imprecision to evaluate the overall performance of analytical methods.
Objectives: To assess the analytical performance of routine biochemical analytes using six sigma metrics and classify analytes according to sigma performance, and to identify analytes that require method improvement.
Methods: A retrospective observational study was conducted at Biochemistry department DRPGMC, Tanda, Himachal Pradesh, India, using Internal Quality Control data and External Quality Assessment (EQA) results of 6 months from a clinical biochemistry laboratory. Imprecision (coefficient of variation [CV %]) was calculated from daily quality control (QC) data, and bias (%) was derived from EQA peer-group mean values. TEa% values were adopted from the Clinical Laboratory Improvement Amendments (CLIA) guidelines. Sigma metrics were calculated using the formula: σ = TEa ˗ ∣Bias∣ ÷ CV. Analytes were categorized into high (≥6σ), moderate (3–5.9σ), and low (<3σ) performance groups to guide QC rule selection.
Results: Sigma metrics varied across analytes and required the TEa criteria applied. When assessed using the CLIA-88 TEa limits, triglycerides and high-density lipoprotein cholesterol (HDL-C) demonstrated high sigma performance (≥6σ), indicating excellent analytical precision. Moderate sigma performance (3–5.9σ) was observed for glucose, uric acid, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, total protein, cholesterol (at level 3), and calcium (at level 3), necessitating multi-rule quality control strategies. In contrast, urea, creatinine, albumin, and phosphorus exhibited poor analytical performance with sigma values <3σ, indicating the need for improving the method. However, when sigma metrics were recalculated using the more stringent CLIA-2025 TEa limits, a further decline in analytical performance was observed. Uric acid, liver enzymes, and total protein demonstrated sigma values <3σ under the revised criteria, whereas triglycerides (at level 3) and HDL-C
consistently maintained high sigma performance (≥6σ) despite the narrower allowable error limits.
Conclusion: Six sigma assessments provided a comprehensive and quantitative measure of analytical quality in a clinical laboratory. Incorporating sigma metrics into routine quality assurance enhances reliability, optimizes QC protocols, and strengthens patient safety.
Downloads
References
[1] Harry M, Schroeder R. Six Sigma: The Breakthrough Management Strategy Revolutionizing the World's Top Corporations. New York, NY: Doubleday; 2000.
[2] Pande PS, Neuman RP, Cavanagh RR. The Six Sigma Way. New York, NY: McGraw-Hill; 2003.
[3] George, M.L. (2003) Lean Six Sigma for Service. McGraw-Hill, New York, NY: McGraw-Hill; 2003.
[4] Westgard S, Bayat H, Westgard JO. Analytical Sigma metrics: Aa review of Six Sigma implementation tools for medical laboratories. Biochem Med (Zagreb). 2018 Jun 15;28(2):020502.
[5] Plebani M. Errors in clinical laboratories or errors in laboratory medicine? Clin Chem Lab Med. 2006;44(6):750-–759.
[6] Coskun A, Unsal I, Serteser M, Inal T. Six Sigma as a Quality Management Tool: Evaluation of Performance in Laboratory Medicine [Internet]. Quality Management and Six Sigma. Sciyo; 2010. https://doi.org/10.5772/9928
[7] Centers for Medicare & Medicaid Services (CMS), Department of Health and Human Services. Clinical Laboratory Improvement Amendments of 1988 (CLIA) proficiency testing regulations related to analytes and acceptable performance (CMS-3355-F). Final rule. Fed Regist. 2022 Jul 11;87(131):41194-41242. Available from: https://www.govinfo.gov/app/details/FR-2022-07-11/2022-14513. Accessed 2025 Dec 19. Centers for Medicare & Medicaid Services (CMS), Department of Health and Human Services (HHS). Clinical Laboratory Improvement Amendments of 1988 (CLIA) proficiency testing regulations related to analytes and acceptable performance (CMS-3355-F). Final rule. Fed Regist. 2022 July 11 [cited 2025 December 19]; 87(132):41376-402.
[8] Hens K, Berth M, Armbruster D, Westgard S. Sigma metrics used to assess analytical quality of clinical chemistry assays: importance of the allowable total error (TEa) target. Clin Chem Lab Med. 2014 Jul;52(7):973-–980.
[9] Westgard JO, Westgard SA. An assessment of σ metrics for analytic quality using performance data from proficiency testing surveys and the CLIA criteria for acceptable performance. J Vet Diagn Invest. 2008; 20:536–544.
[10] International Organization for Standardization (ISO). ISO 15189: Medical Laboratories – Requirements for Quality and Competence. Geneva, Switzerland: ISO,; 2022.
[11] Sciacovelli L, O'Kane M, Skaik YA, Caciagli P, Pellegrini C, Da Rin G, Ivanov A, Ghys T, Plebani M;et al. IFCC WG-LEPS. Quality indicators in laboratory medicine: from theory to practice. Preliminary data from the IFCC Working Group Project "Laboratory Errors and Patient Safety.". Clin Chem Lab Med. 2011 May;49(5):835-844.
[12] Kumar BV, Mohan T. Sigma metrics as a tool for evaluating the performance of internal quality control in a clinical chemistry laboratory. J Lab Physicians. 2018 Apr-–Jun;10(2):194-–199.
[13] Mao X, Shao J, Zhang B, Wang Y. Evaluating analytical quality in clinical biochemistry laboratory using Six Sigma. Biochem Med (Zagreb). 2018 Jun 15;28(2):020904.
[14] Gadde R, Hm V. Analysis of biochemical analytes using Six Sigma metrics with two analyzers at an Indian lab setting. Bioinformation. 2023 Nov 30;19(11):1043-–1050.
[15] Verma M, Dahiya K, Ghalaut VS, Dhupper V. Assessment of quality control system by Sigma metrics and quality goal index ratio: a roadmap towards preparation for NABL. World J Methodol. 2018 Nov 29;8(3):44-–50.
[16] Singh B, Goswami B, Gupta VK, Chawla R, Mallika V. Application of Sigma metrics for the assessment of quality assurance in clinical biochemistry laboratory in India: a pilot study. Indian J Clin Biochem. 2011 Apr;26(2):131-–135.
[17] Karam N, El-Farahaty RM, El-Gilany A-H, Nosser NA. Sigma metrics for assessing the analytical performance of 14 biochemical analytes in Mansoura university children’s hospital laboratories (MUCHLs) using CLIA LIMITS 1988 & 2024. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine. 2025;62(6):431-–439.
[18] Emre HO. Six Sigma in Action: Evaluating Its Practicality in a Multi-Analyzer Laboratory under CLIA 2024 Guidelines. Ann Clin Lab Sci. 2025 May;55(3):416-425. Six Sigma in action: evaluating its practicality in a multi-analyzer laboratory under CLIA 2024 guidelines. Ann Clin Lab Sci. 2025 May-–June 2025 ;55:416-–425.
[19] College of American Pathologists. Laboratory accreditation program [Internet]. Northfield, (IL): College of American Pathologists; [cited 2025 December 13]. Available from: https://www.cap.org/laboratory-improvement/accreditation/laboratory-accreditation-program.
[20] German Medical Association on Quality Assurance in Medical Laboratory Examinations (Rili-BAEK). Revision of the “Guideline of the German Medical Association on Quality Assurance in Medical Laboratory Examinations – Rili-BAEK.”. Lab Med. 2015; 39:26–69.
[21] Royal College of Pathologists of Australasia (RCPA). Allowable limits of performance for biochemistry [Internet]. RCPA; 2021 [cited 2025 December 13]. Available from: www.rcpa.edu.au
Additional Files
Published
Issue
Section
Categories
License
Copyright (c) 2026 Anita Devi, Nisha Dogra, Mimosa Das
This work is licensed under a Creative Commons Attribution 4.0 International License.
The authors retain all proprietary rights, including copyright, such as patent and trademark rights and rights to any process or procedure described in the article.
